Filtros : "Saldanha, Artur" Limpar

Filtros



Refine with date range


  • Source: Journal of thrombosis and thrombolysis. Unidade: FM

    Subjects: DOENÇA DE VON WILLEBRAND, MIELOMA MÚLTIPLO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SALDANHA, Artur et al. Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib. Journal of thrombosis and thrombolysis, v. 55, n. 4, p. 770-774, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53774. Acesso em: 07 nov. 2024.
    • APA

      Saldanha, A., Veiga, M. E., Okazaki, E., Rothschild, C., Martinez, G., Rocha, V. G., et al. (2023). Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib. Journal of thrombosis and thrombolysis, 55( 4), 770-774. doi:10.1007/s11239-023-02799-6
    • NLM

      Saldanha A, Veiga ME, Okazaki E, Rothschild C, Martinez G, Rocha VG, Orsi FA, Villaca P. Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib [Internet]. Journal of thrombosis and thrombolysis. 2023 ; 55( 4): 770-774.[citado 2024 nov. 07 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53774
    • Vancouver

      Saldanha A, Veiga ME, Okazaki E, Rothschild C, Martinez G, Rocha VG, Orsi FA, Villaca P. Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib [Internet]. Journal of thrombosis and thrombolysis. 2023 ; 55( 4): 770-774.[citado 2024 nov. 07 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53774
  • Source: Annals of hematology. Unidade: FM

    Subjects: TROMBOCITOPENIA, SEGURANÇA DO PACIENTE, ESPLENECTOMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SALDANHA, Artur et al. Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia. Annals of hematology, v. 101, n. 12, p. 2781-2784, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50396. Acesso em: 07 nov. 2024.
    • APA

      Saldanha, A., Orsi, F. A., Okazaki, E., Rothschild, C., Prestes, P., Stefanello, B., et al. (2022). Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia. Annals of hematology, 101( 12), 2781-2784. doi:10.1007/s00277-022-04985-7
    • NLM

      Saldanha A, Orsi FA, Okazaki E, Rothschild C, Prestes P, Stefanello B, Alves L, Rocha V, Villaca P. Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia [Internet]. Annals of hematology. 2022 ; 101( 12): 2781-2784.[citado 2024 nov. 07 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50396
    • Vancouver

      Saldanha A, Orsi FA, Okazaki E, Rothschild C, Prestes P, Stefanello B, Alves L, Rocha V, Villaca P. Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia [Internet]. Annals of hematology. 2022 ; 101( 12): 2781-2784.[citado 2024 nov. 07 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50396

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024